annual CFI:
-$7.98B-$3.92B(-96.36%)Summary
- As of today (May 29, 2025), AZN annual cash flow from investing activities is -$7.98 billion, with the most recent change of -$3.92 billion (-96.36%) on December 31, 2024.
- During the last 3 years, AZN annual CFI has risen by +$3.08 billion (+27.84%).
- AZN annual CFI is now -922.68% below its all-time high of $970.00 million, reached on December 31, 2004.
Performance
AZN Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$1.25B-$72.00M(-6.10%)Summary
- As of today (May 29, 2025), AZN quarterly cash flow from investing activities is -$1.25 billion, with the most recent change of -$72.00 million (-6.10%) on March 31, 2025.
- Over the past year, AZN quarterly CFI has increased by +$1.16 billion (+48.07%).
- AZN quarterly CFI is now -166.23% below its all-time high of $1.89 billion, reached on June 30, 2006.
Performance
AZN quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$6.82B+$1.16B(+14.54%)Summary
- As of today (May 29, 2025), AZN TTM cash flow from investing activities is -$6.82 billion, with the most recent change of +$1.16 billion (+14.54%) on March 31, 2025.
- Over the past year, AZN TTM CFI has dropped by -$1.59 billion (-30.38%).
- AZN TTM CFI is now -547.21% below its all-time high of $1.52 billion, reached on June 30, 2005.
Performance
AZN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AZN Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -96.4% | +48.1% | -30.4% |
| 3 y3 years | +27.8% | -645.8% | +42.1% |
| 5 y5 years | -1114.6% | -10000.0% | -598.8% |
AZN Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -169.6% | +27.8% | -645.8% | +56.4% | -130.4% | +44.8% |
| 5 y | 5-year | -2700.0% | +27.8% | -325.8% | +88.0% | -2459.9% | +44.8% |
| alltime | all time | -922.7% | +46.4% | -166.2% | +91.0% | -547.2% | +60.3% |
AZN Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.25B(+6.1%) | -$6.82B(-14.5%) |
| Dec 2024 | -$7.98B(+96.4%) | -$1.18B(-22.0%) | -$7.98B(+1.3%) |
| Sep 2024 | - | -$1.51B(-47.3%) | -$7.88B(+3.9%) |
| Jun 2024 | - | -$2.87B(+19.0%) | -$7.58B(+45.0%) |
| Mar 2024 | - | -$2.41B(+124.0%) | -$5.23B(+28.7%) |
| Dec 2023 | -$4.06B(+37.3%) | -$1.08B(-11.8%) | -$4.06B(+25.6%) |
| Sep 2023 | - | -$1.22B(+134.8%) | -$3.24B(-13.9%) |
| Jun 2023 | - | -$520.00M(-58.3%) | -$3.76B(-6.9%) |
| Mar 2023 | - | -$1.25B(+400.4%) | -$4.04B(+36.4%) |
| Dec 2022 | -$2.96B(-73.2%) | -$249.00M(-85.7%) | -$2.96B(-18.3%) |
| Sep 2022 | - | -$1.74B(+117.9%) | -$3.62B(-70.6%) |
| Jun 2022 | - | -$800.00M(+376.2%) | -$12.35B(+4.8%) |
| Mar 2022 | - | -$168.00M(-81.6%) | -$11.78B(+6.5%) |
| Dec 2021 | -$11.06B(+3780.0%) | -$913.00M(-91.3%) | -$11.06B(+10.5%) |
| Sep 2021 | - | -$10.46B(+4333.9%) | -$10.01B(+8035.8%) |
| Jun 2021 | - | -$236.00M(-142.5%) | -$123.00M(-147.1%) |
| Mar 2021 | - | $555.00M(+302.2%) | $261.00M(-191.6%) |
| Dec 2020 | -$285.00M(-56.6%) | $138.00M(-123.8%) | -$285.00M(-21.9%) |
| Sep 2020 | - | -$580.00M(-491.9%) | -$365.00M(-226.3%) |
| Jun 2020 | - | $148.00M(+1544.4%) | $289.00M(-129.6%) |
| Mar 2020 | - | $9.00M(-84.5%) | -$976.00M(+48.6%) |
| Dec 2019 | -$657.00M(-168.2%) | $58.00M(-21.6%) | -$657.00M(-409.9%) |
| Sep 2019 | - | $74.00M(-106.6%) | $212.00M(-7166.7%) |
| Jun 2019 | - | -$1.12B(-440.5%) | -$3.00M(-100.3%) |
| Mar 2019 | - | $328.00M(-64.6%) | $1.02B(+5.7%) |
| Dec 2018 | $963.00M(-141.4%) | $927.00M(-757.4%) | $963.00M(-160.0%) |
| Sep 2018 | - | -$141.00M(+46.9%) | -$1.61B(-10.8%) |
| Jun 2018 | - | -$96.00M(-135.2%) | -$1.80B(-5.7%) |
| Mar 2018 | - | $273.00M(-116.6%) | -$1.91B(-18.0%) |
| Dec 2017 | -$2.33B(-41.3%) | -$1.64B(+390.1%) | -$2.33B(+2704.8%) |
| Sep 2017 | - | -$335.00M(+63.4%) | -$83.00M(-77.7%) |
| Jun 2017 | - | -$205.00M(+40.4%) | -$372.00M(-69.7%) |
| Mar 2017 | - | -$146.00M(-124.2%) | -$1.23B(-69.1%) |
| Dec 2016 | -$3.97B(-6.4%) | $603.00M(-196.6%) | -$3.97B(-44.5%) |
| Sep 2016 | - | -$624.00M(-41.2%) | -$7.16B(+2.9%) |
| Jun 2016 | - | -$1.06B(-63.2%) | -$6.95B(+5.8%) |
| Mar 2016 | - | -$2.89B(+11.7%) | -$6.57B(+55.0%) |
| Dec 2015 | -$4.24B(-39.7%) | -$2.58B(+515.5%) | -$4.24B(+33.7%) |
| Sep 2015 | - | -$420.00M(-38.1%) | -$3.17B(-4.3%) |
| Jun 2015 | - | -$678.00M(+21.9%) | -$3.31B(-13.1%) |
| Mar 2015 | - | -$556.00M(-63.3%) | -$3.81B(-45.8%) |
| Dec 2014 | -$7.03B(+143.4%) | -$1.52B(+170.2%) | -$7.03B(+7.9%) |
| Sep 2014 | - | -$561.00M(-52.4%) | -$6.52B(-1.3%) |
| Jun 2014 | - | -$1.18B(-68.8%) | -$6.61B(+4.8%) |
| Mar 2014 | - | -$3.78B(+276.2%) | -$6.30B(+118.1%) |
| Dec 2013 | -$2.89B(+55.4%) | -$1.00B(+55.2%) | -$2.89B(+20.4%) |
| Sep 2013 | - | -$647.00M(-26.0%) | -$2.40B(-46.1%) |
| Jun 2013 | - | -$874.00M(+140.1%) | -$4.45B(+58.0%) |
| Mar 2013 | - | -$364.00M(-29.2%) | -$2.82B(+51.5%) |
| Dec 2012 | -$1.86B(-8.1%) | -$514.00M(-80.9%) | -$1.86B(-62.3%) |
| Sep 2012 | - | -$2.70B(-455.0%) | -$4.92B(+415.7%) |
| Jun 2012 | - | $760.00M(+28.2%) | -$955.00M(-37.5%) |
| Mar 2012 | - | $593.00M(-116.6%) | -$1.53B(-24.4%) |
| Dec 2011 | -$2.02B | -$3.58B(-381.4%) | -$2.02B(-282.8%) |
| Sep 2011 | - | $1.27B(+583.9%) | $1.11B(+1102.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | - | $186.00M(+86.0%) | $92.00M(-109.0%) |
| Mar 2011 | - | $100.00M(-122.1%) | -$1.02B(-54.2%) |
| Dec 2010 | -$2.23B(-10.1%) | -$452.00M(-275.2%) | -$2.23B(-39.5%) |
| Sep 2010 | - | $258.00M(-127.9%) | -$3.68B(-15.4%) |
| Jun 2010 | - | -$925.00M(-16.4%) | -$4.35B(+18.8%) |
| Mar 2010 | - | -$1.11B(-41.9%) | -$3.66B(+47.7%) |
| Dec 2009 | -$2.48B(-36.4%) | -$1.90B(+364.4%) | -$2.48B(+129.0%) |
| Sep 2009 | - | -$410.00M(+73.7%) | -$1.08B(+25.8%) |
| Jun 2009 | - | -$236.00M(-418.9%) | -$859.00M(-4.4%) |
| Mar 2009 | - | $74.00M(-114.5%) | -$899.00M(-76.9%) |
| Dec 2008 | -$3.90B(-73.8%) | -$509.00M(+170.7%) | -$3.90B(+1.9%) |
| Sep 2008 | - | -$188.00M(-31.9%) | -$3.82B(+6.4%) |
| Jun 2008 | - | -$276.00M(-90.6%) | -$3.59B(-79.1%) |
| Mar 2008 | - | -$2.92B(+570.4%) | -$17.20B(+15.5%) |
| Dec 2007 | -$14.89B(+5373.2%) | -$436.00M(-1138.1%) | -$14.89B(+5.1%) |
| Sep 2007 | - | $42.00M(-100.3%) | -$14.17B(-4.0%) |
| Jun 2007 | - | -$13.88B(+2156.6%) | -$14.75B(-1552.2%) |
| Mar 2007 | - | -$615.00M(-318.9%) | $1.02B(-473.5%) |
| Dec 2006 | -$272.00M(-77.0%) | $281.00M(-151.8%) | -$272.00M(-75.7%) |
| Sep 2006 | - | -$542.00M(-128.6%) | -$1.12B(-33.0%) |
| Jun 2006 | - | $1.89B(-199.4%) | -$1.67B(-45.4%) |
| Mar 2006 | - | -$1.90B(+236.2%) | -$3.06B(+158.9%) |
| Dec 2005 | -$1.18B(-221.9%) | -$566.00M(-48.2%) | -$1.18B(-212.8%) |
| Sep 2005 | - | -$1.09B(-317.7%) | $1.05B(-31.3%) |
| Jun 2005 | - | $502.00M(-2108.0%) | $1.52B(+1.1%) |
| Mar 2005 | - | -$25.00M(-101.5%) | $1.51B(+55.6%) |
| Dec 2004 | $970.00M(-213.8%) | $1.66B(-370.1%) | $970.00M(-278.3%) |
| Sep 2004 | - | -$616.00M(-226.7%) | -$544.00M(-26.8%) |
| Jun 2004 | - | $486.00M(-186.2%) | -$743.48M(-31.5%) |
| Mar 2004 | - | -$564.00M(-476.0%) | -$1.09B(+27.4%) |
| Dec 2003 | -$852.00M(-44.8%) | $150.00M(-118.4%) | -$852.00M(-43.7%) |
| Sep 2003 | - | -$815.48M(-666.2%) | -$1.51B(+38.0%) |
| Jun 2003 | - | $144.03M(-143.6%) | -$1.10B(-31.0%) |
| Mar 2003 | - | -$330.54M(-35.3%) | -$1.59B(+3.0%) |
| Dec 2002 | -$1.54B(-2.8%) | -$511.27M(+28.2%) | -$1.54B(-2.6%) |
| Sep 2002 | - | -$398.73M(+14.6%) | -$1.58B(+2.8%) |
| Jun 2002 | - | -$348.00M(+22.1%) | -$1.54B(+0.9%) |
| Mar 2002 | - | -$285.00M(-48.5%) | -$1.53B(-3.7%) |
| Dec 2001 | -$1.59B(+22.7%) | -$553.00M(+55.3%) | -$1.59B(+19.5%) |
| Sep 2001 | - | -$356.00M(+6.5%) | -$1.33B(-33.6%) |
| Jun 2001 | - | -$334.12M(-2.8%) | -$2.00B(+48.9%) |
| Mar 2001 | - | -$343.88M(+16.9%) | -$1.34B(+3.8%) |
| Dec 2000 | -$1.29B(+71.8%) | -$294.29M(-71.3%) | -$1.29B(+29.5%) |
| Sep 2000 | - | -$1.03B(-418.4%) | -$999.17M(-3668.0%) |
| Jun 2000 | - | $322.62M(-209.5%) | $28.00M(-109.5%) |
| Mar 2000 | - | -$294.62M | -$294.62M |
| Dec 1999 | -$753.00M(-77.7%) | - | - |
| Dec 1998 | -$3.38B(+489.6%) | - | - |
| Dec 1997 | -$573.63M(+4.7%) | - | - |
| Dec 1996 | -$548.00M(-15.6%) | - | - |
| Dec 1995 | -$648.99M(+44.1%) | - | - |
| Dec 1994 | -$450.26M(+15.7%) | - | - |
| Dec 1993 | -$389.03M(+45.7%) | - | - |
| Dec 1992 | -$266.94M(+30.9%) | - | - |
| Dec 1991 | -$203.96M(+211.0%) | - | - |
| Dec 1990 | -$65.58M | - | - |
FAQ
- What is AstraZeneca annual cash flow from investing activities?
- What is the all time high annual CFI for AstraZeneca?
- What is AstraZeneca annual CFI year-on-year change?
- What is AstraZeneca quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for AstraZeneca?
- What is AstraZeneca quarterly CFI year-on-year change?
- What is AstraZeneca TTM cash flow from investing activities?
- What is the all time high TTM CFI for AstraZeneca?
- What is AstraZeneca TTM CFI year-on-year change?
What is AstraZeneca annual cash flow from investing activities?
The current annual CFI of AZN is -$7.98B
What is the all time high annual CFI for AstraZeneca?
AstraZeneca all-time high annual cash flow from investing activities is $970.00M
What is AstraZeneca annual CFI year-on-year change?
Over the past year, AZN annual cash flow from investing activities has changed by -$3.92B (-96.36%)
What is AstraZeneca quarterly cash flow from investing activities?
The current quarterly CFI of AZN is -$1.25B
What is the all time high quarterly CFI for AstraZeneca?
AstraZeneca all-time high quarterly cash flow from investing activities is $1.89B
What is AstraZeneca quarterly CFI year-on-year change?
Over the past year, AZN quarterly cash flow from investing activities has changed by +$1.16B (+48.07%)
What is AstraZeneca TTM cash flow from investing activities?
The current TTM CFI of AZN is -$6.82B
What is the all time high TTM CFI for AstraZeneca?
AstraZeneca all-time high TTM cash flow from investing activities is $1.52B
What is AstraZeneca TTM CFI year-on-year change?
Over the past year, AZN TTM cash flow from investing activities has changed by -$1.59B (-30.38%)